Therapeutic Efficacy in Women With Stress Urinary Incontinence
Women With Stress Urinary Incontinence
About this trial
This is an interventional treatment trial for Women With Stress Urinary Incontinence
Eligibility Criteria
Inclusion Criteria: Female patients over 25 years old with stress urinary incontinence. Patients who are currently not considered for surgical treatment. Patients who have undergone regular Kegel exercises but have poor results. Exclusion Criteria: The result of urodynamic examination, if the main cause of urinary incontinence is detrusor overactivity. Those who are taking or plan to take monoamine oxidase inhibitor (MAOI) inhibitors. Patients with acute myocardial infarction. Those who are allergic to duloxetine, imipramine and dibenzazepine tricyclic antidepressants. Patients with uncontrolled narrow-angle glaucoma. Pregnant women. Those who are contraindicated to duloxetine or imipramine. Patients with suicidal ideation and behavior.
Sites / Locations
- Department of Obstetrics and Gynecology, Far Eastern Memorial HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Duloxetine
Imipramine